Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Grows By 8.2%

Enzo Biochem, Inc. (NYSE:ENZ) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Based on an average trading volume of 74,600 shares, the days-to-cover ratio is presently 6.9 days. Approximately 1.4% of the shares of the company are short sold.

Enzo Biochem Stock Performance

Shares of NYSE ENZ remained flat at $1.13 during mid-day trading on Thursday. 25,716 shares of the company traded hands, compared to its average volume of 96,630. Enzo Biochem has a twelve month low of $0.99 and a twelve month high of $1.50. The firm’s 50 day moving average price is $1.12 and its 200-day moving average price is $1.12.

Hedge Funds Weigh In On Enzo Biochem

An institutional investor recently raised its position in Enzo Biochem stock. Renaissance Technologies LLC increased its position in shares of Enzo Biochem, Inc. (NYSE:ENZ) by 2.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,499,546 shares of the medical research company’s stock after purchasing an additional 64,417 shares during the period. Renaissance Technologies LLC owned about 4.86% of Enzo Biochem worth $2,725,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 36.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of Enzo Biochem in a report on Monday. They issued a “hold” rating for the company.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.